BlackRock Portfolio holdings
AUM $5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-3.24%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.7T
AUM Growth
-$213B
(-5.4%)
Cap. Flow
+$9.64B
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
20.61%
Holding
5,898
New
116
Increased
2,454
Reduced
2,619
Closed
128
Top Buys
| 1 |
S&P Global
SPGI
|
+$3.38B |
| 2 |
Advanced Micro Devices
AMD
|
+$3.36B |
| 3 |
Tesla
TSLA
|
+$2.58B |
| 4 |
Microsoft
MSFT
|
+$1.45B |
| 5 |
Amazon
AMZN
|
+$1.39B |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.51B |
| 5 |
Exelon
EXC
|
+$1.36B |
Sector Composition
| 1 | Technology | 24.03% |
| 2 | Healthcare | 13.69% |
| 3 | Financials | 12.58% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
UroGen Pharma
URGN
$836M
| $14.8M | ﹤0.01% |
1,700,776
-27,318
| -2% | -$238K |
|
3252
Acacia Research
ACTG
$324M
| $14.8M | ﹤0.01% |
3,281,170
-90,576
| -3% | -$408K |
|
3253
Mizuho Financial
MFG
$83.2B
| $14.6M | ﹤0.01% |
5,697,964
+1,526,316
| +37% | +$3.92M |
|
3254
TPG
TPG
$9.07B
| $14.6M | ﹤0.01% |
+483,884
| New | +$14.6M |
|
|
DALS
3255
DELISTED
DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
| $14.6M | ﹤0.01% |
1,501,060
| – | – |
|
|
TPBA
3256
DELISTED
TPB Acquisition Corporation I Class A Ordinary Share
TPBA
| $14.6M | ﹤0.01% |
1,499,800
| – | – |
|
3257
VistaGen Therapeutics
VTGN
$99.7M
| $14.5M | ﹤0.01% |
391,081
-5,392
| -1% | -$201K |
|
|
LUNA
3258
DELISTED
Luna Innovations Incorporated
LUNA
| $14.5M | ﹤0.01% |
1,884,605
-22,034
| -1% | -$170K |
|
3259
BlackRock Intermediate Muni Income Bond ETF
INMU
$139M
| $14.5M | ﹤0.01% |
600,000
-50,000
| -8% | -$1.21M |
|
3260
Citius Pharmaceuticals
CTXR
$19.4M
| $14.5M | ﹤0.01% |
323,287
-1,843
| -0.6% | -$82.5K |
|
3261
AerSale
ASLE
$407M
| $14.4M | ﹤0.01% |
917,919
+327,380
| +55% | +$5.15M |
|
|
LOGC
3262
DELISTED
ContextLogic
LOGC
| $14.4M | ﹤0.01% |
213,405
+18,791
| +10% | +$1.27M |
|
3263
Roblox
RBLX
$95.1B
| $14.4M | ﹤0.01% |
311,209
+226,029
| +265% | +$10.5M |
|
|
SRRA
3264
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $14.4M | ﹤0.01% |
448,430
+424,985
| +1,813% | +$13.6M |
|
3265
ACM Research
ACMR
$1.91B
| $14.3M | ﹤0.01% |
693,370
-12,452
| -2% | -$258K |
|
3266
Aldeyra Therapeutics
ALDX
$306M
| $14.3M | ﹤0.01% |
3,220,511
-8,300
| -0.3% | -$36.9K |
|
3267
Taysha Gene Therapies
TSHA
$824M
| $14.3M | ﹤0.01% |
2,193,703
-839,260
| -28% | -$5.47M |
|
3268
Citizens
CIA
$273M
| $14.3M | ﹤0.01% |
3,366,176
-95,982
| -3% | -$407K |
|
3269
Nkarta
NKTX
$140M
| $14.3M | ﹤0.01% |
1,253,706
-44,625
| -3% | -$508K |
|
3270
Vanguard Russell 1000 ETF
VONE
$6.81B
| $14.3M | ﹤0.01% |
68,822
+46,105
| +203% | +$9.55M |
|
3271
Blue Ridge Bankshares
BRBS
$387M
| $14.2M | ﹤0.01% |
937,804
-22,437
| -2% | -$340K |
|
3272
Merus
MRUS
$5.15B
| $14.2M | ﹤0.01% |
536,800
-160,822
| -23% | -$4.25M |
|
3273
Origin Materials
ORGN
$79.2M
| $14.2M | ﹤0.01% |
2,155,334
+3,613
| +0.2% | +$23.8K |
|
3274
Distribution Solutions Group
DSGR
$1.46B
| $14.2M | ﹤0.01% |
734,582
-3,250
| -0.4% | -$62.6K |
|
3275
Lightwave Logic
LWLG
$406M
| $14.2M | ﹤0.01% |
1,473,021
+38,426
| +3% | +$369K |
|